Skip to main content

Activation of Prodrugs by Antibody-Enzyme Conjugates

  • Chapter
Immunobiology of Proteins and Peptides VI

Abstract

Monoclonal antibodies (MAbs) against human tumor antigens have been the subject of extensive investigation as carriers of cytotoxic agents to tumor cells. Promising results, both in vitro and in vivo, have been obtained in studies involving immunoconjugates such as MAb-toxins (Vitetta et al., 1987; Blakey et al., 1988), MAb-drugs (Pietersz, 1990; Koppel, 1990), and radiolabeled MAbs (Goldenberg, 1990). Based on these findings, many such conjugates are currently being evaluated in the clinic.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Bagshawe, K.D., 1989, Towards generating cytotoxic agents at cancer sites. Br. J. Cancer, 60:275.

    Article  PubMed  CAS  Google Scholar 

  • Bagshawe, K.D., Springer, C.J., Searle, F., Antoniw P., Sharma, S.K., Melton, R.G., Sherwood, R.F.A., 1988, Cytotoxic agent can be generated selectively at cancer sites, Br. J. Cancer. 58:700.

    Article  PubMed  CAS  Google Scholar 

  • Blakey, D.C., Wawrzynczak, E.J., Wallace, P.M., Thorpe, P.E., 1988, Antibody toxin conjugates: a perspective. Prog. Allergy. 45:50.

    PubMed  CAS  Google Scholar 

  • Bukhari, M.A., Everett, J.L., and Ross, W.C.J. Glucuronic, Sulphuric and Phosphoric Esters of p-Di-2-chloroethylaminophenol. Biochem. Pharm., 21:963.

    Google Scholar 

  • Clark, E.A., Shu, G., Ledbetter, J.A., 1985, Role of the bp35 cell surface polypeptide in human B-cell activation. Proc. Natl. Acad. Sci. USA. 82:1766.

    Article  PubMed  CAS  Google Scholar 

  • Goldenberg, D.M., 1990, Cancer Imaging with Radiolabeled Antibodies,Kluwer Academic Publishers, Boston.

    Google Scholar 

  • Hellstrom, K.E., Yelton, D.E., Fell, H.P., Beaton, D., Gayle, M., MacLean, M., Kahn, M., Hellstrom, I., 1990. Epitope mapping and use of anti-idiotypic antibodies to the L6 monoclonal antibody. Cancer Res., 50: 2449.

    PubMed  CAS  Google Scholar 

  • Hellstrom, I., Horn, D., Linsley, P., Brown, J.P., Brankovan, V., Hellstrom, K.E., 1986, Monoclonal mouse antibodies raised against human lung carcinoma. Cancer Res., 46:3917.

    PubMed  CAS  Google Scholar 

  • Kerr, D.E., Senter, P.D., Burnett, W.V., Hirschberg, D.L., Hellstrom, I., and Hellstrom, K.E., 1990, Antibody-penicillin-V-amidase conjugates kill antigen-positive tumor cells when combined with doxorubicin phenoxyacetamide, Cancer Immunol. Immunother., 31:202.

    Article  PubMed  CAS  Google Scholar 

  • Koppel, G.A., 1990, Recent advances with monoclonal antibody drug targeting for the treatment of human cancer. Bioconj. Chem., 1:13.

    Article  CAS  Google Scholar 

  • Pietersz, G.A., 1990, The linkage of cytotoxic drugs to monoclonal antibodies for the treatment of cancer. Bioconj. Chem., 1:89.

    Article  CAS  Google Scholar 

  • Sands, H., Jones, P.L., Shah, S.A., Plame, D., Vessella, R.C., and Gallagher, B.M., 1988, Correlation of vascular permeability and blood flow with monoclonal antibody uptake by human clouser and renal cell xenografts. Cancer Res., 48:188.

    PubMed  CAS  Google Scholar 

  • Senter, P.D., Activation of prodrugs by antibody-enzyme conjugates: A new approach to cancer therapy. FASEB. 4:188.

    Google Scholar 

  • Senter, P.D., Saulnier, M.G., Schreiber, G.J., Hirschberg, D.L., Brown, J.P., Hellstrom, L, Hellstrom, K.E., 1988, Anti-tumor effect of antibody-alkaline phosphatase conjugates in combination with etoposide phosphate. Proc. Natl. Acad. Sci. USA. 85:4842.

    Article  PubMed  CAS  Google Scholar 

  • Senter, P.D., Schreiber, G.J., Hirschberg, D.L., Ashe, S.A., Hellstrom, K.E., Hellstrom, L, 1990, Enhancement of the in vitro and in vivo antitumor activities of phosphorylated mitomycin C and etoposide derivatives by monoclonal antibody-alkaline phosphatase conjugates. Cancer Res., 49:5789.

    Google Scholar 

  • Stanislawski, M., Rousseau, V., Goavec, M., Ito, H., 1989, Immunotoxins containing glucose oxidase and lactoperoxidase with tumoricidal properties: In vitro killing effectiveness in a mouse plasmacytoma cell model Cancer Res., 49:5497.

    PubMed  CAS  Google Scholar 

  • Thorpe, P.E., 1985, Antibody carriers of cytotoxic agents in cancer therapy: a review, in: “Monoclonal antibodies’ 84: biological and clinical applications,” Editrice Kurtis, Milan.

    Google Scholar 

  • Vitetta, E.S., Fulton, R.J., May, R.D., Till, M., Uhr, J.W., 1987, Redesigning nature’s poisons to create anti-tumor reagents. Science. 238:1098.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1991 Plenum Press, New York

About this chapter

Cite this chapter

Senter, P.D., Wallace, P.M., Svensson, H.P., Kerr, D.E., Hellstrom, I., Hellstrom, K.E. (1991). Activation of Prodrugs by Antibody-Enzyme Conjugates. In: Atassi, M.Z. (eds) Immunobiology of Proteins and Peptides VI. Advances in Experimental Medicine and Biology, vol 303. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-6000-1_12

Download citation

  • DOI: https://doi.org/10.1007/978-1-4684-6000-1_12

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4684-6002-5

  • Online ISBN: 978-1-4684-6000-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics